Liraglutide API Technology

Liraglutide API Technology

Products
Liraglutide API Technology
Liraglutide API Technology

Information

AVVA Pharmaceuticals is seeking partners to license it's developed API manufacturing technology recombinant Liraglutide. This technology encompasses many improvements vs the originator for the production of a cost competitive medicine. Technical support could be provided for the FDF stage
Main Categories
Biopharmaceuticals
All Categories
Bio process technologiesBiopharmaceuticals
AVVA Pharmaceuticals LtdAVVA Pharmaceuticals Ltd is a European based pharmaceutical company, aiming on becoming a reference innovation hub for the development of biological medicines and new small molecules, with ultimate goal on providing a meaningful and affordable healthcare. The company focuses on developing biosimilars and biological medicines in partnership with leading international research and scientific centers. Our portfolio includes a number of inventions that will replace current standards in the fields of infectious and metabolic diseases.

Log in

See all the content and easy-to-use features by logging in or registering!